Mark Bradley
@markrbradley.bsky.social
Thought Leader | Healthcare Strategist | ISPEP | Founder/CEO
Subscribe to my Healthcare Collaboration Newsletter: https://www.linkedin.com/newsletters/healthcare-collaboration-7191729402316017664/
Subscribe to my Healthcare Collaboration Newsletter: https://www.linkedin.com/newsletters/healthcare-collaboration-7191729402316017664/
Improving #patientoutcomes and advancing #endocrine #research through real-world #data #registries
This ensures that decisions are informed by real-world #evidence, leading to more precise #diagnoses, enhanced #therapies, and better #health #management #strategies.
ow.ly/xUoM50VRrkl
#SfE
This ensures that decisions are informed by real-world #evidence, leading to more precise #diagnoses, enhanced #therapies, and better #health #management #strategies.
ow.ly/xUoM50VRrkl
#SfE
May 27, 2025 at 3:11 PM
Improving #patientoutcomes and advancing #endocrine #research through real-world #data #registries
This ensures that decisions are informed by real-world #evidence, leading to more precise #diagnoses, enhanced #therapies, and better #health #management #strategies.
ow.ly/xUoM50VRrkl
#SfE
This ensures that decisions are informed by real-world #evidence, leading to more precise #diagnoses, enhanced #therapies, and better #health #management #strategies.
ow.ly/xUoM50VRrkl
#SfE
Can you help us bridge the gap in menopause research?
Most #women worldwide experience #menopausal #symptoms during the transition or post-menopause.
Yet there is a clear unmet need to assess #outcomes for #efficacy and #safety of #menopause #treatments.
ow.ly/9JNq50VYeuH
#PROMMIS #PeopleWith
Most #women worldwide experience #menopausal #symptoms during the transition or post-menopause.
Yet there is a clear unmet need to assess #outcomes for #efficacy and #safety of #menopause #treatments.
ow.ly/9JNq50VYeuH
#PROMMIS #PeopleWith
May 27, 2025 at 2:57 PM
Can you help us bridge the gap in menopause research?
Most #women worldwide experience #menopausal #symptoms during the transition or post-menopause.
Yet there is a clear unmet need to assess #outcomes for #efficacy and #safety of #menopause #treatments.
ow.ly/9JNq50VYeuH
#PROMMIS #PeopleWith
Most #women worldwide experience #menopausal #symptoms during the transition or post-menopause.
Yet there is a clear unmet need to assess #outcomes for #efficacy and #safety of #menopause #treatments.
ow.ly/9JNq50VYeuH
#PROMMIS #PeopleWith